Skip to main content
VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
2.320
+0.030 (1.31%)
At close: Dec 5, 2025, 4:00 PM EST
2.280
-0.040 (-1.72%)
After-hours: Dec 5, 2025, 7:58 PM EST

VivoSim Labs Revenue

VivoSim Labs had revenue of $28.00K in the quarter ending September 30, 2025, a decrease of -6.67%. This brings the company's revenue in the last twelve months to $140.00K, up 35.92% year-over-year. In the fiscal year ending March 31, 2025, VivoSim Labs had annual revenue of $144.00K with 32.11% growth.

Revenue (ttm)
$140.00K
Revenue Growth
+35.92%
P/S Ratio
34.14
Revenue / Employee
$10,769
Employees
13
Market Cap
6.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025144.00K35.00K32.11%
Mar 31, 2024109.00K-261.00K-70.54%
Mar 31, 2023370.00K-1.13M-75.33%
Mar 31, 20221.50M--
Mar 31, 2021---
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

VIVS News

More News